Literature DB >> 12768031

Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A.

Pierre Génin1, Pierre Morin, Ahmet Civas.   

Abstract

Two members of the signal transducer and activator of transcription family, STAT1 and STAT2, form, together with interferon regulatory factor 9 (IRF-9), the ISGF3 complex that activates the expression of the interferon-stimulated genes (ISG). The ISGF3 complex also participates in the virus-induced alpha/beta interferon (IFN-alpha/beta) gene amplification cascade by up-regulating IRF-7 gene expression. Here, we show that treatment of cells with trichostatin A (TSA), a deacetylase inhibitor, inhibits the virus-induced activation of IFN-alpha/beta promoters and dramatically reduces the ability of different ISG promoters to respond to IFN stimulation. Impairment of IFN-alpha/beta and ISG expression by TSA in infected cells is due to the blockage of interferon-stimulated ISGF3 complex formation, which leads to the abolition of IRF-7 gene expression. We also show that the TSA-dependent inhibition of ISGF3 is related to impaired nuclear accumulation of STAT2. Our data suggest that an acetylation/deacetylation mechanism participates in the regulation of cellular distribution and function of STAT2 in IFN-alpha/beta signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768031      PMCID: PMC156205          DOI: 10.1128/jvi.77.12.7113-7119.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion.

Authors:  D E Levy; A García-Sastre
Journal:  Cytokine Growth Factor Rev       Date:  2001 Jun-Sep       Impact factor: 7.638

2.  A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1.

Authors:  R L Haspel; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 3.  STAT family of transcription factors in cytokine-mediated biological responses.

Authors:  K Takeda; S Akira
Journal:  Cytokine Growth Factor Rev       Date:  2000-09       Impact factor: 7.638

Review 4.  IRF family of transcription factors as regulators of host defense.

Authors:  T Taniguchi; K Ogasawara; A Takaoka; N Tanaka
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain.

Authors:  A Begitt; T Meyer; M van Rossum; U Vinkemeier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 6.  Acetylation of histones and transcription-related factors.

Authors:  D E Sterner; S L Berger
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

7.  Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7.

Authors:  R Lin; P Génin; Y Mamane; J Hiscott
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  Inhibition of histone deacetylation induces constitutive derepression of the beta interferon promoter and confers antiviral activity.

Authors:  E Shestakova; M T Bandu; J Doly; E Bonnefoy
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

9.  Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation.

Authors:  R Lu; W C Au; W S Yeow; N Hageman; P M Pitha
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

10.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

View more
  22 in total

1.  Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity.

Authors:  Hao-Ming Chang; Matthew Paulson; Michelle Holko; Charles M Rice; Bryan R G Williams; Isabelle Marié; David E Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

2.  The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.

Authors:  Christopher A Alvarez-Breckenridge; Jianhua Yu; Richard Price; Min Wei; Yan Wang; Michal O Nowicki; Yoonhee P Ha; Stephen Bergin; Christine Hwang; Soledad A Fernandez; Balveen Kaur; Michael A Caligiuri; E Antonio Chiocca
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses.

Authors:  Anastassia V Komarova; Chantal Combredet; Laurène Meyniel-Schicklin; Manuel Chapelle; Grégory Caignard; Jean-Michel Camadro; Vincent Lotteau; Pierre-Olivier Vidalain; Frédéric Tangy
Journal:  Mol Cell Proteomics       Date:  2011-09-12       Impact factor: 5.911

4.  Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.

Authors:  Ahmed Abdulwahid Salman; Mohammed Hussein Waheed; Akeel Abd Ali-Abdulsahib; Zeenah Weheed Atwan
Journal:  Biomed Rep       Date:  2021-03-09

5.  Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.

Authors:  Luna A Zaritsky; Jacquelyn R Bedsaul; Kathryn C Zoon
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

6.  Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence.

Authors:  Isha Sengupta; Dipanwita Das; Shivaram Prasad Singh; Runu Chakravarty; Chandrima Das
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

7.  Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammation.

Authors:  Heeyoung Yang; Sang-Myeong Lee; Beixue Gao; Jinping Zhang; Deyu Fang
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

8.  Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.

Authors:  Thi Lien-Anh Nguyên; Hesham Abdelbary; Meztli Arguello; Caroline Breitbach; Simon Leveille; Jean-Simon Diallo; Amber Yasmeen; Tarek A Bismar; David Kirn; Theresa Falls; Valerie E Snoulten; Barbara C Vanderhyden; Joel Werier; Harold Atkins; Markus J V Vähä-Koskela; David F Stojdl; John C Bell; John Hiscott
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

9.  Potentiation and tolerance of toll-like receptor priming in human endothelial cells.

Authors:  Stephen R Koch; Fred S Lamb; Judith Hellman; Edward R Sherwood; Ryan J Stark
Journal:  Transl Res       Date:  2016-08-08       Impact factor: 7.012

Review 10.  Regulation of STAT signaling by acetylation.

Authors:  Shougang Zhuang
Journal:  Cell Signal       Date:  2013-05-22       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.